Gyermekkori daganatok: vizsgálatok itt: Kanada
152 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleDinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Where
- Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
- Életkor
- Up to 30 év
- People
- 478 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06172296 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Calgary, Montreal, Toronto
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - No phaseTaking peopleMet Non Small Cell Cancer Registry (MOMENT)
- Where
- Ottawa, Québec, Toronto, Vancouver
- People
- 700 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT05376891 - 2. fázisNot yet taking people in KanadaAdaptive Radiotherapy for Safe Hypofractionation
- Where
- Montreal
- People
- 264
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT07516210 - No phaseBefejeződöttCollection of Tissue Samples for Cancer Research
- Where
- Toronto
- Életkor
- 2 hónap and over
- People
- 5000 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00900198 - 2. fázisTaking peopleA Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Calgary, Edmonton, Halifax, Hamilton, Montreal, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- 366 nap to 46 év
- People
- 222 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06124157 - 1/2. fázisFelfüggesztveStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Montreal, Toronto
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- London, Montreal, Toronto
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 3. fázisTaking peopleA Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Where
- Calgary, Toronto
- People
- 115 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT03394365 · EU 2024-516622-57-00 - 2. fázisTaking peopleA Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
- Where
- Calgary, Edmonton, Montreal, Sherbrooke, Toronto
- Életkor
- Up to 21 év
- People
- 50 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06064097 - 1. fázisTaking peopleCLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
- Where
- Calgary, Ottawa, Toronto, Vancouver
- Életkor
- 1 év and over
- People
- 24
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT06208735 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Montreal, Toronto
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Toronto
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1. fázisTaking peopleZiftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Where
- Toronto
- Életkor
- 0 év to 21 év
- People
- 20 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT06376162 · EU 2023-505262-28-00 - No phaseTaking peopleCfDNA in Hereditary And High-risk Malignancies 2
- Where
- Halifax, Montreal, St. John's, Toronto, Vancouver
- Életkor
- Up to 90 év
- People
- 1000
- Run by
- University Health Network, Toronto
See details and how to joinNCT06726642 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 1/2. fázisTaking peopleA Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Where
- Calgary, Toronto
- Életkor
- 1 hónap to 17 év
- People
- 50 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00 - No phaseTaking peopleProton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy
- Where
- Toronto
- Életkor
- Up to 21 év
- People
- 5000 worldwide
- Run by
- Massachusetts General Hospital
See details and how to joinNCT01696721 - 1/2. fázisTaking peopleA Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
- Where
- Montreal, Toronto
- People
- 64 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07602777 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Calgary, Edmonton, Montreal, Ottawa
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - No phaseNot yet taking people in KanadaEvaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer
- Where
- London
- People
- 25
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT07510906 - 1/2. fázisTaking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Edmonton, Toronto
- Életkor
- 12 év and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - 3. fázisTaking peopleEffect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
- Where
- Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- 7 év to 21 év
- People
- 140 worldwide
- Run by
- Donald Mabbott
See details and how to joinNCT05230758 - 2. fázisTaking peopleA Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
- Where
- Calgary, Edmonton, Halifax, Hamilton, Montreal, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- 3 év to 29 év
- People
- 160 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04684368 - 2. fázisCsak meghívásosLong-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
- Where
- Montreal, Ottawa, Québec, Toronto, Vancouver
- People
- 1500 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00